These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 1716671)

  • 21. Enhancement of epidermal growth factor receptor expression on glioma cells by recombinant tumor necrosis factor alpha.
    Adachi K; Belser P; Bender H; Li D; Rodeck U; Benveniste EN; Woo D; Schmiegel WH; Herlyn D
    Cancer Immunol Immunother; 1992; 34(6):370-6. PubMed ID: 1563013
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antitumor effect of exogenous/endogenous TNF (EET) therapy with cyclophosphamide on C6 glioma in rat.
    Ohshiro S; Inagawa H; Soma G; Fukushima T; Tomonaga M
    Cancer Biother; 1994; 9(4):359-67. PubMed ID: 7719383
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Boron neutron capture therapy of brain tumors: enhanced survival and cure following blood-brain barrier disruption and intracarotid injection of sodium borocaptate and boronophenylalanine.
    Barth RF; Yang W; Rotaru JH; Moeschberger ML; Boesel CP; Soloway AH; Joel DD; Nawrocky MM; Ono K; Goodman JH
    Int J Radiat Oncol Biol Phys; 2000 Apr; 47(1):209-18. PubMed ID: 10758326
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Studies on anti-tumor activity of tumor necrosis factor alpha against human renal cell carcinoma cells heterotransplanted into nude mice].
    Shibayama T; Tachibana M; Tazaki H; Nakamura K
    Nihon Hinyokika Gakkai Zasshi; 1991 Oct; 82(10):1611-9. PubMed ID: 1770700
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhanced delivery of boronophenylalanine for neutron capture therapy by means of intracarotid injection and blood-brain barrier disruption.
    Yang W; Barth RF; Carpenter DE; Moeschberger ML; Goodman JH
    Neurosurgery; 1996 May; 38(5):985-92. PubMed ID: 8727825
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Boron neutron capture therapy of brain tumors: enhanced survival following intracarotid injection of sodium borocaptate with or without blood-brain barrier disruption.
    Yang W; Barth RF; Rotaru JH; Moeschberger ML; Joel DD; Nawrocky MM; Goodman JH; Soloway AH
    Int J Radiat Oncol Biol Phys; 1997 Feb; 37(3):663-72. PubMed ID: 9112465
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recombinant human TNF-alpha: preclinical studies and results from early clinical trials.
    Saks S; Rosenblum M
    Immunol Ser; 1992; 56():567-87. PubMed ID: 1550875
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of intracarotid infusion of etoposide: modification of the permeability of the blood-brain barrier and the blood-tumor barrier in rat brain tumor model.
    Maeda Y; Matsumoto K; Mizumatsu S; Tamiya T; Furuta T; Ohmoto T
    Acta Med Okayama; 1999 Feb; 53(1):5-11. PubMed ID: 10096732
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of recombinant tumour necrosis factor alpha on blood flow and antibody localisation in human tumour xenografts in nude mice.
    Pimm MV; Gribben SJ; Morris TM
    J Cancer Res Clin Oncol; 1991; 117(6):543-8. PubMed ID: 1744160
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Histopathological and blood-brain barrier changes in rats induced by an intracerebral injection of human recombinant interleukin 2.
    Watts RG; Wright JL; Atkinson LL; Merchant RE
    Neurosurgery; 1989 Aug; 25(2):202-8. PubMed ID: 2788827
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiangiogenic gene therapy in a rat glioma model using a dominant-negative vascular endothelial growth factor receptor 2.
    Machein MR; Risau W; Plate KH
    Hum Gene Ther; 1999 May; 10(7):1117-28. PubMed ID: 10340544
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor necrosis factor and interleukin-1 protection against the lethal effects of tumor necrosis factor.
    Sheppard BC; Norton JA
    Surgery; 1991 Jun; 109(6):698-705. PubMed ID: 2042087
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence that Cereport's ability to increase permeability of rat gliomas is dependent upon extent of tumor growth: implications for treating newly emerging tumor colonies.
    Bartus RT; Snodgrass P; Dean RL; Kordower JH; Emerich DF
    Exp Neurol; 2000 Jan; 161(1):234-44. PubMed ID: 10683290
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-tumor activity of recombinant tumor necrosis factor on mouse fibrosarcoma in vivo and in vitro.
    Tomazic VJ; Farha M; Loftus A; Elias EG
    J Immunol; 1988 Jun; 140(11):4056-61. PubMed ID: 3372997
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention and treatment of endotoxin and sepsis lethality with recombinant human tumor necrosis factor.
    Sheppard BC; Fraker DL; Norton JA
    Surgery; 1989 Aug; 106(2):156-61; discussion 161-2. PubMed ID: 2669193
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microvascular permeability in induced astrocytomas and peritumor neuropil of rat brain. A high-voltage electron microscope-protein tracer study.
    Shivers RR; Edmonds CL; Del Maestro RF
    Acta Neuropathol; 1984; 64(3):192-202. PubMed ID: 6496036
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of blood-brain barrier permeability and the effect of interferon in mouse glioma model.
    Wiranowska M; Gonzalvo AA; Saporta S; Gonzalez OR; Prockop LD
    J Neurooncol; 1992 Nov; 14(3):225-36. PubMed ID: 1281226
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antitumor activity of recombinant human tumor necrosis factor-alpha (rH-TNF alpha) and liposome-entrapped rH-TNF alpha.
    Wakabayashi T; Yoshida J; Ishiyama J; Mizuno M
    Neurol Med Chir (Tokyo); 1997 Oct; 37(10):739-45; discussion 745-6. PubMed ID: 9362133
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective increase in blood-tumor barrier permeability by calcium antagonists in transplanted rat brain tumors.
    Matsukado K; Nomura T; Ikezaki K; Fukui M
    Acta Neurochir Suppl (Wien); 1994; 60():403-5. PubMed ID: 7526626
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Morphological effects of tumor necrosis factor-alpha on the blood vessels in rat experimental brain tumors.
    Isaka T; Yoshimine T; Maruno M; Hayakawa T
    Neurol Med Chir (Tokyo); 1996 Jul; 36(7):423-7. PubMed ID: 8741370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.